MINERALYS THERAPEUTICS INC (MLYS) Stock Income Statement
NASDAQ:MLYS - US6031701013 - Common Stock
34 USD
+0.88 (+2.66%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 203.07M | 192.40M | 84.66M | 31.48M | 18.73M | |||
| Research and Development | 174.71M | 168.58M | 70.36M | 26.25M | 16.31M | |||
| Selling, General, and Administrative Expenses | 28.36M | 23.82M | 14.30M | 5.23M | 2.42M | |||
| Operating Income | -203.07M | -192.40M | -84.66M | -31.48M | -18.73M | |||
| Interest Income/Expense | 12.30M | 14.59M | 12.76M | 1.68M | -684.00K | |||
| Other Income/Expense | -3.00K | 5.00K | 3.00K | 4.00K | 1.00K | |||
| Income Before Taxes | -190.77M | -177.81M | -71.90M | -29.80M | -19.41M | |||
| Net Income | -190.77M | -177.81M | -71.90M | -29.80M | -19.41M | |||
| EBITDA | -203.01M | -192.36M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.57 | -3.66 | -1.99 | -0.80 | -0.52 | |||
| Non GAAP EPS | -3.56 | -3.64 | -2.00 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD